Intelligent Pills Global Market Report 2025

The intelligent pills market size has grown rapidly in recent years. It will grow from $7.31 billion in 2024 to $8.29 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth during the historic period can be credited to the rising demand for personalized medicine, the increased adoption of smart healthcare devices, the growing incidence of chronic diseases, greater investments in digital healthcare technologies, and the heightened need for remote patient monitoring.

The intelligent pills market size is expected to see rapid growth in the next few years. It will grow to $13.55 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to the increasing demand for real-time health data, growing adoption of the Internet of Medical Things (IoMT), a rising number of health-conscious consumers, enhanced capabilities in healthcare data management, and the expanding use of telemedicine. Key trends expected during the forecast period include the development of artificial intelligence-powered pills, the emergence of self-regulating pills, integration with mobile health applications, connectivity with wearable devices, and advancements in bio-sensing technology.

The increasing prevalence of lifestyle-related disorders is expected to drive the growth of the intelligent pills market in the coming years. Lifestyle-related disorders are non-communicable diseases largely caused or influenced by individuals' daily habits, behaviors, and lifestyle choices. The rise in these disorders is mainly attributed to unhealthy dietary patterns, which lead to conditions such as obesity, heart disease, diabetes, and other chronic illnesses. Intelligent pills support personalized treatment for lifestyle-related conditions by enabling real-time health monitoring, offering data-driven insights, enhancing medication adherence, and improving therapeutic outcomes. For example, in September 2023, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that in 2022, 22 states had an adult obesity rate of 35% or higher, up from 19 states in 2021. Hence, the growing incidence of lifestyle-related disorders is contributing to the expansion of the intelligent pills market.

Leading companies in the intelligent pills market are concentrating on the development of technologically advanced solutions, such as digital health products, to improve patient monitoring and boost medication adherence. Digital health products encompass technology-driven tools and platforms - including mobile health applications, wearable devices, smart pills, and telemedicine systems - that support real-time monitoring, management, and enhancement of health outcomes. For example, in September 2022, HealthBeacon plc, an Ireland-based therapeutics company, launched the HB Smart Pills Management System to improve medication management for patients with complex pill routines. This system provides features such as medication reminders, refill notifications, image capture of pill containers to ensure adherence, and actionable insights for both patients and healthcare providers to support more effective medication management. It is specifically designed to help patients follow complicated medication schedules, thereby minimizing missed doses and enhancing treatment outcomes.

In April 2022, AARDEX Group, a digital health company based in Belgium, formed a partnership with etectRx Inc. to combine their digital medication adherence technologies, enabling real-time tracking of pill ingestion. The goal of this collaboration is to enhance adherence monitoring in clinical trials by integrating AARDEX’s analytics software with etectRx’s ingestible sensor, delivering real-time, objective data to improve patient outcomes. etectRx Inc. is a U.S.-based digital health company that specializes in intelligent pills.

Major players in the intelligent pills market are Medtronic plc, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Otsuka Pharmaceutical Co. Ltd., Lonza Group AG, Olympus Corporation, Lloyds Pharmacy Limited, STRATACACHE Inc., Check-Cap Ltd., Proteus Digital Health Inc., CapsoVision Inc., Medisafe Inc., IntroMedic Co. Ltd., Jinshan Science And Technology (Group) Co. Ltd., Innurvation Inc., AARDEX Group SA, BodyCap SAS, AnX Robotica Corp., EtectRx Inc., and Given Imaging Ltd.

North America was the largest region in the intelligent pills market in 2024. The regions covered in intelligent pills report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intelligent pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Intelligent pills, often referred to as smart pills, are ingestible devices equipped with sensors and wireless technology designed to monitor and transmit data from inside the body. These pills serve medical purposes, including monitoring patient adherence, diagnosing medical conditions, and delivering targeted drug treatments.

The primary types of intelligent pills address conditions such as occult gastrointestinal (GI) bleeding, Crohn’s disease, small bowel tumors, celiac disease, inherited polyposis syndromes, and neurological disorders. Occult GI bleeding involves internal bleeding in the digestive system that is not visibly apparent and is typically detected through medical testing. These pills are intended for use in areas including the esophagus, stomach, small intestine, and large intestine. They are applied in procedures such as capsule endoscopy, drug administration, and patient monitoring, and are utilized by various end users including hospital pharmacies, clinics, research institutions, and home healthcare providers.

The intelligent pills market research report is one of a series of new reports that provides intelligent pills market statistics, including the intelligent pills industry's global market size, regional shares, competitors with the intelligent pills market share, detailed intelligent pills market segments, market trends and opportunities, and any further data you may need to thrive in the intelligent pills market. These intelligent pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intelligent pills market consists of revenues earned by entities by providing services such as patient and treatment management, brainstorm-as-a-service, precision pitch crafting, and cyber health checks. The market value includes the value of related goods sold by the service provider or included within the service offering. The intelligent pills market also includes sales of ingestible sensors, pH-sensitive capsules, temperature-monitoring pills, targeted drug delivery capsules, and capsules with wireless communication capabilities. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.